Now they will have a lot more tests to market to those companies. The reason the revenue was low was because their suite of tests was very limited. I've seen several people ridicule that 1.5 million figure but apparently not realize that THI will now have more to offer. The fact that they already have established relationships with those 7 companies is what's important.
(10)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links